Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Condition:   Mantle Cell Lymphoma Interventions:   Drug: Acalabrutinib;   Procedure: Biospecimen Collection;   Procedure: Bone Marrow Biopsy;   Procedure: Computed Tomography;   Procedure: Echocardiography;   Biological: Glofitamab;   Procedure: Multigated Acquisition Scan;   Biological: Obinutuzumab;   Procedure: Positron  Emission Tomography Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials